Trial Profile
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 14 Mar 2023 Planned End Date changed from 1 Jun 2022 to 1 Jan 2025.
- 14 Mar 2023 Planned primary completion date changed from 1 Jan 2021 to 1 Jan 2024.
- 10 Feb 2020 Planned primary completion date changed from 1 Jan 2020 to 1 Jan 2021.